Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018616 · ClinicalTrials.gov registry record · Phase 2
Improving Compliance With Metformin
A Phase 2 study of Diabetes, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT00018616 is a Phase 2 study of Diabetes that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 79 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00018616, a Phase 2 study of Diabetes, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.
Conditions Studied
Interventions
- BEHAVIORAL MEMS caps
Study Locations (1)
Connecticut
- VA Connecticut Health Care System (West Haven) - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 1999-10 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018616
The ClinicalTrials.gov registry entry for NCT00018616 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which MEMS caps is the first listed.
NCT00018616 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00018616 about?
NCT00018616 is a clinical study titled "Improving Compliance With Metformin". This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.
What is the current status of trial NCT00018616?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 1999-10. Estimated completion is 2005-01.
What conditions does trial NCT00018616 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00018616?
The interventions under investigation include: MEMS caps (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018616?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00018616 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
RECRUITING · Phase 2
-
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ACTIVE NOT RECRUITING · Phase 2
-
Biomarker Guided Therapies in Stage A/B Heart Failure
COMPLETED · Phase 2
-
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial
COMPLETED · Phase 2
-
Effects of Human Leptin Replacement
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.